Cabozantinib,Sunitinib
Pfizer
['bladder', 'sunitinib', 'cabozantinib', 'renal,(-adrenal)']
dr. andrew johns discussed findings from a phase ii study of cabozantinib versus sunitinib for non-clear cell renal cell carcinoma (abstract 4597). #asco23 #kidneycancer #bladdercancer #endcancer (4/9) 
MD Anderson is a global leader in cancer care, research, education and training, and prevention. Appointments available: 1-877-632-6789